HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Suzhou Zelgen Biopharmaceuticals (688266.CH) - Uncertainty Leads to Inaccurate Prediction on Outlook

China Healthcare Weekly (Mar.4)-Innovative Drug Cyclical Nature, Pet Vaccine Mkt, Legend Bio, Junshi

Russia-Ukraine War: The Impact on China Healthcare

Pre-IPO ADICON Holdings Ltd - Insights on Industry, Business and Concerns

Presentation on Apr.12: 2021 High Conviction Ideas - Topchoice Medical (600763.CH)

Pre-IPO Yonghe Medical Group - Here Are the Concerns

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

Equity Capital Markets

<p>In recent years, with the steady improvement of residents' consumption level, people's attention to dental care is also increasing, which promotes the rapid development of private dental clinics in China. On July 1, 2021, <a href="https://www.smartkarma.com/entities/arrail-group-limited" target="_blank" data-smartkarma-citation="entities:33794:1" rel="noopener">Arrail Group (ARR HK)</a>, the largest premium private dental services provider in China, formally submitted its IPO prospectus to the HKEX, aiming to list on the main board. However, if look closely, Arrail is actually facing many challenges, and its outlook may not be optimistic. This insight mainly analyzed the concerns of the Company that worth the investors’ attention. </p>

In recent years, with the steady improvement of residents' consumption level, people's attention to dental care is also increasing, which promotes the rapid development of private dental clinics in China. On July 1, 2021, Arrail Group (ARR HK), the largest premium private dental services provider in China, formally submitted its IPO prospectus to the HKEX, aiming to list on the main board. However, if look closely, Arrail is actually facing many challenges, and its outlook may not be optimistic. This insight mainly analyzed the concerns of the Company that worth the investors’ attention. 

Pre-IPO Arrail Group - The Outlook May Not Be Optimistic